Axolotl Biologix has a total of 12 patents globally. Out of these 12 patents, more than 91% patents are active. The United States of America is where Axolotl Biologix has filed the maximum number of patents. Parallelly, The United States of America seems to be the main focused R&D center and also the origin country of Axolotl Biologix.
Axolotl Biologix was founded in the year 2016. Axolotl Biologix is a biotechnology company that uses technology, research, and clinical applications to create regenerative medicine.
Do read about some of the most popular patents of Axolotl Biologix which have been covered by us in this article and also you can find Axolotl Biologix patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Axolotl Biologix patent portfolio.
How many patents does Axolotl Biologix have?
Axolotl Biologix has a total of 12 patents globally. These patents belong to 1 unique patent family. Out of 12 patents, 11 patents are active.
How Many Patents did Axolotl Biologix File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Axolotl Biologix Applications Filed | Axolotl Biologix Patents Granted |
| 2022 | 4 | – |
| 2021 | 1 | – |
| 2020 | 7 | – |
How many Axolotl Biologix patents are Alive/Dead?
Worldwide Patents
How Many Patents did Axolotl Biologix File in Different Countries?
Countries in which Axolotl Biologix Filed Patents
| Country | Patents |
| United States Of America | 3 |
| Mexico | 1 |
| India | 1 |
| Canada | 1 |
| Brazil | 1 |
| New Zealand | 1 |
| Chile | 1 |
| Australia | 1 |
| Europe | 1 |
Where are Research Centers of Axolotl Biologix Patents Located?
The Research Centre for all the Axolotl Biologix patents is the United States of America.
List of Axolotl Biologix Patents
| Axolotl Biologix | Title |
| US20220305061A1 | Compositions Derived From Human Amnion Cells & Related Methods |
| US20220152119A1 | Compositions Derived From Human Amnion Cells & Related Methods |
| US20220133807A1 | Compositions Derived From Human Amnion Cells & Related Methods |
| EP4009993A4 | Compositions Derived From Human Amnion Cells & Related Methods |
| CA3145800A1 | Compositions Derived From Human Amnion Cells & Related Methods |
| AU2020327956A1 | Compositions Derived From Human Amnion Cells And Related Methods |
| IN202117062199A | Compositions Derived From Human Amnion Cells & Related Methods |
| CL202200103A1 | Compositions Derived From Human Amnios Cells And Related Methods |
| MX2022001631A | Compositions Derived From Human Amnion Cells & Related Methods. |
| BR112022000502A2 | Method For Preparing A Cellular Human Amnion-Derived Composition Configured For Therapeutic Use, Method For Treatment A Subject Suffering From Degenerative Joint Disease, And Human Amnion-Derived Composition |
| NZ784017A | Compositions Derived From Human Amnion Cells & Related Methods |
| WO2021030292A1 | Compositions Derived From Human Amnion Cells & Related Methods |
What are Axolotl Biologix key innovation segments?
What Technologies are Covered by Axolotl Biologix?
The chart below distributes patents filed by Axolotl Biologix